OVERVIEW

The 2024 Boston University Ophthalmology Update and Haimovici Symposium is designed for practicing ophthalmologists, optometrists, ophthalmic technicians and medical personnel involved in the diagnosis and treatment of eye disease. In this program, national and departmental experts will discuss the most advanced medical and surgical treatment options for ophthalmic conditions such as retinal diseases, thyroid eye disease, glaucoma and cornea. This conference is designed to address gaps in knowledge and competence in these areas.

It also includes the Haimovici Lecture. Named in honor of Robert Haimovici, MD, beloved retina specialist who served as the Director of the Retina Service at Boston Medical Center and BUSM from 1994 until his death in 2002, this lecture honors his dedication and professionalism and his deep commitment to education.

TARGET AUDIENCE

This program is for the healthcare team involved in the diagnosis and treatment of eye disease including ophthalmologists, optometrists and ophthalmic technicians.

LEARNING OBJECTIVES 

At the end of this program, participants will be able to:

1. Summarize the definition of thyroid eye disease (TED). 
2. Discuss the current treatment options and indications and limitations of treatment modalities for TED.
3. Describe the current ophthalmic agents available for first line and/or adjunctive treatment of glaucoma.
4. Review of updates in glaucoma diagnostics (OCT and VF).
5. List and review the current treatment algorithm for keratoconus
6. List and review the current treatment algorithm for neurotrophic keratitis.
7. Review of refractive options and indications to become glasses free.
8. Evaluate for drug toxicity in the retina.
9. Describe updates in diagnosis and treatment of ocular melanoma.
10. List secondary intraocular implants options.
11. List the current available retina injectables for retinal disorders.
12. Describe when a secondary implant is appropriate and how to choose a secondary implant.
13. Review the treatment for diabetic retinopathy based upon diabetic studies.
14. Outline how to connect ocular findings to dementia.

ACCREDITATION

In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 6.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.